PTX Media related, page-1294

Coverage of the "Future of Cancer Therapy" and the approval of the mutliple myeloma treatment was just on the Today show too.

Its the first positive step towards personalised Car T therapy becoming the future norm in cancer treatment. This is the beginnings of the ecosystem that PTX is positoning itself to be part of in a big way.

Has anyone considered how the cost of our upcoming OmniCAR trials will be dramatically reduced if we partner with other companies with licensiing platforms? Combining platforms such as OmniCAR, CellPryme and say another platform using different T-cell type... and run the trials here in Aust could knock the ball out of the park in terms of efficacy and safety. And Peter Mac are pushing to get the first trials in solid tumors started here in Aust.

Bec's tweets throughout the ISCT have me thinking that tomorrow's webinar and release of new pre-clincal data could be based on investigative R&D involving other cell types and stem cells. Work investigating allogeneic manufacturing too could be on the cards! That would be exciting news.